Cargando…
A Novel Homozygous GPAA1 Variant in a Patient with a Glycosylphosphatidylinositol Biosynthesis Defect
Glycosylphosphatidylinositol biosynthesis defect 15 is a rare autosomal recessive disorder due to biallelic loss of function of GPAA1. At the moment, less than twenty patients have been reported, usually compound heterozygous for GPAA1 variants. The main clinical features are intellectual disability...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379968/ https://www.ncbi.nlm.nih.gov/pubmed/37510348 http://dx.doi.org/10.3390/genes14071444 |
_version_ | 1785080091209891840 |
---|---|
author | Fontana, Paolo Budillon, Alberto Simeone, Domenico Del Vecchio Blanco, Francesca Caiazza, Martina D’Amico, Alessandra Lonardo, Fortunato Nigro, Vincenzo Limongelli, Giuseppe Scarano, Gioacchino |
author_facet | Fontana, Paolo Budillon, Alberto Simeone, Domenico Del Vecchio Blanco, Francesca Caiazza, Martina D’Amico, Alessandra Lonardo, Fortunato Nigro, Vincenzo Limongelli, Giuseppe Scarano, Gioacchino |
author_sort | Fontana, Paolo |
collection | PubMed |
description | Glycosylphosphatidylinositol biosynthesis defect 15 is a rare autosomal recessive disorder due to biallelic loss of function of GPAA1. At the moment, less than twenty patients have been reported, usually compound heterozygous for GPAA1 variants. The main clinical features are intellectual disability, hypotonia, seizures, and cerebellar atrophy. We describe a 4-year-old male with a novel, homozygous variant. The patient presents with typical features, such as developmental delay, hypotonia, seizures, and atypical features, such as macrocephaly, preauricular, and cheek appendages. When he was 15 months, the cerebellum was normal. When he was 33 months old, after the molecular diagnosis, magnetic resonance imaging was repeated, showing cerebellar atrophy. This case extends the clinical spectrum of the GPAA1-related disorder and helps to delineate phenotypic differences with defects of other subunits of the transamidase complex. |
format | Online Article Text |
id | pubmed-10379968 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103799682023-07-29 A Novel Homozygous GPAA1 Variant in a Patient with a Glycosylphosphatidylinositol Biosynthesis Defect Fontana, Paolo Budillon, Alberto Simeone, Domenico Del Vecchio Blanco, Francesca Caiazza, Martina D’Amico, Alessandra Lonardo, Fortunato Nigro, Vincenzo Limongelli, Giuseppe Scarano, Gioacchino Genes (Basel) Case Report Glycosylphosphatidylinositol biosynthesis defect 15 is a rare autosomal recessive disorder due to biallelic loss of function of GPAA1. At the moment, less than twenty patients have been reported, usually compound heterozygous for GPAA1 variants. The main clinical features are intellectual disability, hypotonia, seizures, and cerebellar atrophy. We describe a 4-year-old male with a novel, homozygous variant. The patient presents with typical features, such as developmental delay, hypotonia, seizures, and atypical features, such as macrocephaly, preauricular, and cheek appendages. When he was 15 months, the cerebellum was normal. When he was 33 months old, after the molecular diagnosis, magnetic resonance imaging was repeated, showing cerebellar atrophy. This case extends the clinical spectrum of the GPAA1-related disorder and helps to delineate phenotypic differences with defects of other subunits of the transamidase complex. MDPI 2023-07-14 /pmc/articles/PMC10379968/ /pubmed/37510348 http://dx.doi.org/10.3390/genes14071444 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Fontana, Paolo Budillon, Alberto Simeone, Domenico Del Vecchio Blanco, Francesca Caiazza, Martina D’Amico, Alessandra Lonardo, Fortunato Nigro, Vincenzo Limongelli, Giuseppe Scarano, Gioacchino A Novel Homozygous GPAA1 Variant in a Patient with a Glycosylphosphatidylinositol Biosynthesis Defect |
title | A Novel Homozygous GPAA1 Variant in a Patient with a Glycosylphosphatidylinositol Biosynthesis Defect |
title_full | A Novel Homozygous GPAA1 Variant in a Patient with a Glycosylphosphatidylinositol Biosynthesis Defect |
title_fullStr | A Novel Homozygous GPAA1 Variant in a Patient with a Glycosylphosphatidylinositol Biosynthesis Defect |
title_full_unstemmed | A Novel Homozygous GPAA1 Variant in a Patient with a Glycosylphosphatidylinositol Biosynthesis Defect |
title_short | A Novel Homozygous GPAA1 Variant in a Patient with a Glycosylphosphatidylinositol Biosynthesis Defect |
title_sort | novel homozygous gpaa1 variant in a patient with a glycosylphosphatidylinositol biosynthesis defect |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379968/ https://www.ncbi.nlm.nih.gov/pubmed/37510348 http://dx.doi.org/10.3390/genes14071444 |
work_keys_str_mv | AT fontanapaolo anovelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect AT budillonalberto anovelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect AT simeonedomenico anovelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect AT delvecchioblancofrancesca anovelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect AT caiazzamartina anovelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect AT damicoalessandra anovelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect AT lonardofortunato anovelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect AT nigrovincenzo anovelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect AT limongelligiuseppe anovelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect AT scaranogioacchino anovelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect AT fontanapaolo novelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect AT budillonalberto novelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect AT simeonedomenico novelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect AT delvecchioblancofrancesca novelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect AT caiazzamartina novelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect AT damicoalessandra novelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect AT lonardofortunato novelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect AT nigrovincenzo novelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect AT limongelligiuseppe novelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect AT scaranogioacchino novelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect |